Science
Immune Continuum
Immunoglobulin E (IgE) in Allergic Conditions
Ozureprubart
Clinical Trials
GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
READ MORE
PRESS RELEASES
Year
2026
2025
2024
2023
2022
Filter
August 31 | 2015
FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925
February 23 | 2015
Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline with Agreement to Acquire Flexus Biosciences, Inc.
You are leaving RAPT.com to go to the eczema clinical trial study site.
